Anti-inflammatory effect of chitosan oligosaccharides in RAW 264.7 cells * E-mail: cghyun@jejuhidi.or.kr Abstract: We examined the effects of chitosan oligosaccharides (COSs) with different molecular weights (COS-A, 10 kDa < MW < 20 kDa; COS-C, 1 kDa < MW < 3 kDa) on the lipopolysaccharide (LPS)-induced production of prostaglandin E 2 and nitric oxide and on the expression of cyclooxygenase-2 and inducible nitric oxide synthase in RAW264.7 macrophages. COS-A (0.4%) and COS-C (0.2%) significantly inhibited PGE 2 production in LPS-stimulated macrophages without cytotoxicity. The effect of COS-A and COS-C on COX-2 expression in activated macrophages was also investigated by immunoblotting. The inhibition of PGE 2 by COS-A and COS-C can be attributed to the blocking of COX-2 protein expression. COS-A (0.4%) and COS-C (0.2%) also markedly inhibited the LPS-induced NO production of RAW 264.7 cells by 50.2% and 44.1%, respectively. The inhibition of NO by COSs was consistent with decreases in inducible nitric oxide synthase (iNOS) protein expression. To test the inhibitory effects of COS-A and COS-C on other cytokines, we also performed ELISA assays for IL-1ß in LPS-stimulated RAW 264.7 macrophage cells, but only a dose-dependent decrease in the IL-1ß production exerted by COS-A was observed. In order to test for irritation and the potential sensitization of COS-A and COS-C for use as cosmetic materials, human skin primary irritation tests were performed on 32 volunteers; no adverse reactions of COSs usage were observed. Based on these results, we suggest that COS-A and COS-C be considered possible anti-inflammatory candidates for topical application.
Introduction
Waste materials from the shells of crabs and shrimps are currently utilized as a major industrial source of biomass for large-scale production of chitosan. Chitosan, which is biodegradable, nontoxic, and biocompatible, has been shown to be particularly useful in many fields, including those of food, cosmetics, biomedicine, agriculture, and environmental protection [1] [2] [3] [4] [5] . However, their high molecular weight and high viscosity may limit their uses in vivo. Therefore, recent studies on chitosan have attracted interest in converting chitosan to chitosan oligosaccharides (COSs), because COSs are not only water-soluble but also possess versatile functional properties similar to those of chitosan.
Prostaglandin (PG)E 2 is a major metabolite of the cyclooxygenase (COX) enzyme. COX exists in at least 2 different isoforms, i.e., COX-1 and COX-2. While COX-1 is constitutively expressed in most tissues and is thought to be responsible for regulating normal physiological functions, COX-2 is induced in macrophages, fibroblasts, and several other cell types by proinflammatory stimuli [6, 7] . Furthermore, COX-2 is responsible for the production of large amounts of proinflammatory PGs at inflammatory sites. Therefore, as chronic phases of inflammation and infection correlate strongly with the increased production of PGE 2 , substances that inhibit PGE 2 production could be of therapeutic benefit [8] [9] [10] . Recently, it was reported that COS could inhibit nitric oxide (NO) formation in macrophage RAW 264.7 cells [11] . However, the molecular events underlying the anti-inflammatory effects caused by COSs remain to be elucidated. In this study, therefore, we prepared chitooligosaccharides (COSs) with different molecular weights (COS-A and COS-C) via enzymatic scission. We also investigated the effects of COSs on PGE 2 , NO, and IL-1β production from lipopolysaccharide (LPS)-stimulated mouse RAW cells.
Experimental Procedures

Preparation of COSs
Water-soluble COSs were prepared from 1% (w/v) chitosan in a dual reactor system. Chitosan (1%, w/v) was dissolved in acetic acid. The dual reactor system was composed of a column reactor packed with immobilized chitosanase and an ultrafiltration membrane. Chitosan was partially hydrolyzed using the packed column reactor, and this partially hydrolyzed chitosan was then applied to a substrate feed tank with an ultrafiltration membrane reactor to produce COS-A. In COS-C, acetic acid was replaced by citric acid. Water-soluble COS-A (10 kDa < MW < 20 kDa) and COS-C (1 kDa < MW < 3 kDa) were prepared by passing the ultrafiltration membranes (molecular weight cutoffs of 20000-10000 for the membrane for COS-A and 3000-1000 for the membrane for COS-C). Detailed procedures for their preparation and characterization have been described in our previous paper [12] .
Cell culture
The mouse macrophage-like cell line, RAW 264.7, was purchased from the Korean Cell Line Bank (KCLB; Seoul, Korea). RAW 264.7 cells were cultured in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum (FBS; GIBCO Inc., NY, USA) and 100 U/ml of penicillin/streptomycin. The cells were incubated at 37°C in a humidified, 5% CO 2 atmosphere. To stimulate the cells, the medium was regularly replaced with fresh DMEM, and bacterial LPS (1 μg/ml) was added in the presence or absence of COSs at 0.05-0.4% concentrations.
MTT assay for cell viability
Cell viability was determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. RAW 264.7 cells were cultured in 96-well plates for 18 h, followed by treatment with LPS (1 μg/ml) in the presence of various concentrations of COS-A (0.1-0.4%) and COS-C (0.05 -0.2%). After 24 h incubation, MTT was added to the medium for 4 h. Finally, the supernatant was removed and the formazan crystals were dissolved in dimethyl sulfoxide (DMSO). Absorbance was measured at 540 nm (PowerWave X340; Bio-Tek instruments, VT, USA). The percentage of cells showing cytotoxicity was determined relative to the control group [13, 14] .
Measurement of nitric oxide concentration
Nitric oxide (NO) production was assayed by measuring the nitrite in the supernatants of cultured RAW 264.7 cells as described previously [15, 16] . The cells were seeded at 2.5 × 10 5 cells/ml in 24-well culture plates and cultured for 18 h. The cells were stimulated with LPS (1 μg/ml) and various concentrations (0.05-0.4%) COSs for 24 h and briefly centrifuged. The supernatant was mixed with an equal volume of Griess reagent (1% sulfanilamide, 0.1% naphthylethylenediamine dihydrochloride, and 2.5% phosphoric acid), and incubated at room temperature for 10 min. The concentrations of nitrite were measured by reading at 540 nm. Nitrite production was determined by comparing the optical density with the standard curve obtained with sodium nitrite. All experiments were performed in triplicate.
Measurement of prostaglandin E 2 production
The RAW 264.7 cells were cultured in 24-well culture plates (2.5 × 10 5 cells/ml). COS-A (0.1-0.4%), COS-C (0.05-0.2%), and LPS (1 μg/ml) were added to the culture medium, and incubated at 37°C for 24 h. After the incubation period, the culture supernatant was collected, and the amount of PGE 2 was determined with a PGE 2 Enzyme Immuno-Assay Kit (R&D Systems, Minneapolis, MN, USA) according to the manufacturer's instructions. All experiments were performed in triplicate.
Immunoblotting
Cellular proteins were extracted from LPS (1 μg/ml) stimulated and non-stimulated RAW 264.7 cells. Cells were collected and washed twice with cold phosphatebuffered saline (PBS) and lysed in a lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Nonidet P-40, 2 mM EDTA, 1 mM EGTA, 10 mM NaF, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, 25 μg/ml aprotinin, and 25 μg/ml leupeptin), and kept on ice for 30 min. The cell lysates were centrifuged at 12,000 × g at 4°C for 15 min, and the supernatants were stored at -70°C until use. The protein concentration was measured by the Bradford method [17] . Aliquots of the lysates (30-50 μg of protein) were separated on 8-12% sodium dodecyl sulfate (SDS)-polyacrylamide gels and transferred onto polyvinylidene fluoride (PVDF) membranes (BioRad, Hercules, CA, USA) with a glycine transfer buffer (192 mM glycine, 25 mM Tris-HCl, pH 8.8, and 20% MeOH (v/v). After blocking nonspecific sites with 5% nonfat dried milk, the membrane was incubated with specific primary mouse monoclonal anti-iNOS Ab (1:2500; Calbiochem, La Jolla, CA, USA) or rabbit polyclonal anti-COX-2 Ab (1:2500; BD Biosciences Pharmingen, San Jose, CA, USA) at 4°C overnight. Each membrane was further incubated for 30 min with a secondary peroxidase-conjugated goat IgG (1:5000; Amersham Pharmacia Biotech, Little Chalfont, UK) to mouse and rabbit. Immunoactive proteins were detected using an enhanced chemiluminescence (ECL) western blotting detection kit (Amersham Biosciences, NJ, USA).
Human skin primary irritation test
Thirty-two healthy female Korean subjects were selected based on inclusion and exclusion criteria, and written consent was obtained in each case. The average age was 39.94±6.81 years (range, 20-49 years). The subjects had neither any history of allergic contact dermatitis nor used topical or systemic irritant preparations in the previous 1 month. An IQ Ultra Chamber ® was secured to the back of each subject using micropore tape. The circular rim of the chamber was placed firmly against the skin, causing tight occlusion of the test materials. COS-C preparations formulated with water was applied at 1% concentration. The patches (chambers) remained in place for 48 h. During this time, the subjects abstained from showering or performing any work or exercise that might wet or loosen the patches. Once the patches were removed, the site was evaluated at 30 min and 24 h after application; the readings were scored according to the Cosmetic, Toiletry, and Fragrance Association (CTFA) guidelines [18] .
Statistical analysis
All data are presented as mean ± S.D. Significant differences between groups were determined using unpaired Student's t-tests.
Results
Since previous studies have shown that COS inhibited the production of NO, tumor necrosis factor (TNF)-α, and IL-6 in LPS-induced RAW 264.7 macrophage cells [11] , the focus of this study was to clarify the relationship between PGE 2 production and IL-1β expression following LPS stimuli in RAW 264.7 cells. For this purpose, we previously prepared COSs with different molecular weights (COS-A and COS-C) via enzymatic scission (Figure 1) . To reinvestigate the effect of COS-A and COS-C on NO production, we measured the accumulation of nitrite, a stable oxidized product of NO, in the culture media. NO production was examined in RAW 264.7 cells stimulated by LPS in the presence or absence of COSs for 24 h. Nitrite levels in LPS-stimulated cells increased significantly compared to levels in control cells. As shown in Figure 2 , COS-A (0.4%) and COS-C (0.2%) markedly inhibited the LPSinduced NO production of RAW 264.7 cells by 50.2% and 44.1%, respectively. As determined by MTT assays, neither COS-A (0.1-0.4%) nor COS-C (0.05-0.2%), seem to affect the viability of cells after 24 h, whereas cell viability of COS-C dropped slightly to 88%, for the higher concentrations (above 0.2%). Thus despite some cytotoxicity, little to no impact on cell viability was observed with both COSs within the working concentration range. Our result confirmed the inhibitory effects of COS-A and COS-C on NO production [11] . It is known that PGE 2 plays an important role in the inflammatory process. Several reports have also previously shown that LPS strongly activates macrophages and induces the COX-2 genes, leading to the synthesis of PGE 2 [19, 20] . Therefore, we 5 cells/ml) were stimulated with LPS (1 μg/ml) in the COS-A and COS-C for 24 h. Whole-cell lysate (25 μg) were prepared and the protein level was subjected to 8-12% SDS-PAGE and expression of iNOS, COX-2, and ß-actin were determined by western blotting. One of two representative experiments is shown. examined the effects of COSs on PGE 2 production in LPS-stimulated RAW 264.7 macrophages. When macrophages were stimulated with LPS (1 μg/ml) for 24 h, the levels of PGE 2 increased in the culture medium. As shown in Figure 3 , COS-A and COS-C (0.05-0.4%) suppressed LPS-induced PGE 2 production. To further evaluate whether reduced NO and PGE 2 syntheses correlated with iNOS and COX-2 protein expression, we examined iNOS and COX-2 protein levels by western blot analysis. Although no iNOS or COX-2 protein was detected in unstimulated RAW 264.7 cells, 130-kDa iNOS-and 70-kDa COX-2-specific bands appeared when cells were stimulated with LPS for 24 h. As shown in Figure 4 , COS-A and COS-C each reduced the expression of iNOS protein. The correlation of the amount of iNOS protein with the accumulation of NO suggests that COS-A and COS-C inhibited NO production by reducing iNOS protein expression. We also found that the amounts of the 70-kDa COX-2 protein were increased by LPS, and these increases were antagonized by 0.2-0.4% concentrations of COS-A and COS-C. Several proinflammatory gene products that mediate a critical role in inflammation have been identified. Among these gene products are TNF-α and the members of its superfamily, such as IL-1ß, IL-6, etc. Therefore, whether suppressed or not, these proinflammatory cytokines and mediators provide the key to evaluating novel anti-inflammatory agents. For this reason, we further investigated the effects of COS-A and COS-C on IL-1β production in LPS-stimulated RAW 264.7 macrophages. As shown in Figure 5 , the IL-1β production is inhibited by COS-A in a dose-dependent manner. On the other hand, COS-C did not significantly affect IL-1β production. To test the potential application of COSs as a cosmetic material, human skin primary irritation tests were performed on normal skin (upper back) of 32 volunteers to determine whether any material in COS-A and COS-C (each 1% concentration) caused irritation or potential sensitization. In our study, based on the 48 h and 72 h readings, none of the 32 subjects experienced a reaction. Moreover, we did not observe any severe adverse reactions, such as erythema, burning or pruritus, which are associated with the topical treatment with COS-A and COS-C (Table 1) 
Discussion
Chitosan, which is biodegradable, nontoxic, and biocompatible, is particularly useful in many industrial fields, including in food, cosmetics, biomedicine, agriculture, and environmental protection [4, 5] . However, its high molecular weight has limited its practical applications due to its insolubility [21, 22] . Therefore, recent studies on chitosan have investigated its conversion to COS, because COSs not only are water-soluble but also possess versatile functional properties. Until now, the reported biological activity of chitosan and COSs have been known to be closely related to the molecular weight and degree of acetylation [23] . However, the results published so far have been sometimes contradictory. For example, some authors have reported that chitosan is more effective than COS as an antibacterial agent, while others have claimed that an increase in molecular weight decreases the activity of chitosan [24] [25] [26] [27] [28] [29] . In a previous study, we prepared three types of COSs with different molecular weights (COS-A, COS-B, and COS-H) and a citrate derivative of COS-H via enzymatic scission, and evaluated their antibacterial and antioxidant activities [12] . Actually, in the case of NO inhibition of the three types of COSs, which was performed by our group, only two COSs-COS-A and COS-C-suppressed the production of NO and PGE 2 in LPS-stimulated RAW264.7 cells. These apparent contradictions must therefore be taken into account whenever the anti-inflammatory activities of COSs are applied. The results from the present study suggest that cotreatment with LPS and COS-A or COS-C significantly inhibited LPS-induced NO and PGE 2 production in the murine macrophage cell line model. While evaluating cell viability by using the MTT assay, it was observed that COS-A or COS-C did not affect cell viability at lower concentrations. This suppression correlated with the downregulated gene expression of iNOS and COX-2. However COS-A and COS-C also decreased the viability when the macrophages were treated with a higher concentration (data not shown). Interestingly, we found that the cell viability was increased by COS-A at 0.1% concentration. This implied that COS-A possessed double-edged function. There are several reports that chitosans and their complexes are involved in cell proliferation, resulting in wound healing [30] [31] [32] [33] [34] . Therefore, we expected that COS-A may be used in wound healing and/or anti-wrinkle at below 0.1% concentration. However, we cannot exclude the possible involvement of other functions, and further investigations will focus on the in vitro and in vivo assessment of the biological activity of COS-A in a low concentration.
Although the anti-inflammatory effects of COSs were identified, their mechanism of action has not been fully elucidated. To date, several important common pathways in their functioning have been identified. One such pathway involves the transcription factornuclear factor (NF)-κB-as it controls the expression of proinflammatory genes such as cytokines, adhesion molecules, and cytotoxic molecule-generating enzymes, including iNOS and COX-2. Therefore, many people are trying to develop potent inhibitors of NF-κB as novel anti-inflammatory drugs. It is possible that COSs inhibit NF-κB activation induced by LPS. Finally, to test the application of COSs as cosmetic materials, we previously performed the MTT assay in human cell lines, such as human dermal fibroblast cells [12] . To evaluate the irritation effect of COS-A and COS-C for clinical applications to human skin, a patch test was also performed in this study. In our study, as shown in Table 1 , none of the 32 subjects experienced a reaction based on the 48 and 72 h readings. Specifically, we did not observe any adverse reactions such as erythema, burning or pruritus in the study subjects that was related to the topical treatment of COS-A and COS-C. Considering these results, we suggest that COS-A and COS-C be considered possible anti-inflammatory candidates for topical application.
